Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer
Clinical trial NCT00054275 · COMPLETED
Trial details
- NCT number
- NCT00054275
- Sponsor
- Paula Silverman, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-12-01
- Primary completion
- 2010-04-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.